Aristos Aristidou | Biomaterials | Biomaterials Excellence

Biomaterials Excellence

Aristos Aristidou
Name Aristos Aristidou
Affiliation Texas A&M University
Country United States
Scopus ID 6602073871
Documents 27
Citations 1,547
h-index 20
Subject Area Biomaterials
Event International Material Scientist Awards
ORCID 0000-0002-4873-3639

Aristos Aristidou is a researcher associated with Texas A&M University (TAMU), United States. His research profile highlights biomaterials as a principal subject area, with broader research interests spanning biochemical engineering, metabolic engineering, biomanufacturing, and materials-related applications. Publicly available research-profile information further associates his work with interdisciplinary research at the intersection of engineering, biotechnology, and advanced materials. [1]

Abstract

This academic recognition profile presents the research record of Aristos Aristidou, affiliated with Texas A&M University (TAMU), United States, in the context of biomaterials and related interdisciplinary research. The supplied Scopus profile information identifies 27 documents, 1,547 citations, and an h-index of 20. These bibliometric indicators provide a quantitative overview of indexed scholarly output and citation activity. [1]

Keywords

Aristos Aristidou; Biomaterials; Texas A&M University; TAMU; Materials Science; Biomedical Materials; Biochemical Engineering; Metabolic Engineering; Biomanufacturing; Bioengineering; Advanced Biomaterials; Sustainable Biomanufacturing; Materials Engineering; Biotechnology; Scopus; Research Impact; h-index; Academic Excellence; International Material Scientist Awards. [2]

Introduction

Biomaterials research encompasses the design, development, characterization, and application of materials that interact with biological systems. Its scope intersects materials science, biotechnology, chemical engineering, biomedical engineering, and related disciplines. Within this broader research landscape, interdisciplinary approaches can contribute to the development of functional materials and scalable biological or biochemical processes. [1]

Research Profile

The supplied profile records 27 documents, 1,547 citations, and an h-index of 20 for Aristos Aristidou. These values represent the bibliometric snapshot supplied for this article and may change as Scopus updates indexed records and citation data. Scopus supports author identification through author names, affiliations, and Scopus Author Identifiers. [3]

Research Contributions

The research profile associated with Aristos Aristidou indicates an interdisciplinary orientation involving biochemical engineering, metabolic engineering, bioprocess development, and biomanufacturing. Publicly available research-profile information associates his work with areas including metabolic engineering, fermentation, sustainable biomanufacturing, and engineering applications, illustrating the connection between biological production systems and engineering-oriented research. [4]

Publications

The supplied Scopus record reports 27 indexed documents for Aristos Aristidou. A documented publication associated with his research is Metabolic engineering applications to renewable resource utilization, published in Current Opinion in Biotechnology. Publication counts can differ among databases because of indexing coverage and document types. [3]

Research Impact

The reported citation count and h-index provide quantitative indicators of scholarly visibility. For a balanced assessment, citation indicators should be considered together with publication quality, research leadership, collaboration, technological relevance, intellectual contributions, and evidence of influence within the relevant scientific community. Author identifiers such as Scopus Author IDs and ORCID can also assist with author identification and record disambiguation. [1]

Award Suitability

The reported Scopus indicators—27 documents, 1,547 citations, and an h-index of 20—provide quantitative evidence that may support an award evaluation, but they should not be treated as the sole basis for selection. A comprehensive assessment can additionally consider originality, publication quality, research relevance, technological or translational significance, collaboration, and documented contributions to biomaterials and related scientific fields. [2]

Conclusion

Taken together, the supplied bibliometric information provides a structured basis for considering the researcher’s suitability within a material-science recognition framework. Final award evaluation should incorporate verified publication records, research quality, originality, field relevance, and other documented scholarly contributions in addition to bibliometric indicators. [4]

References

  1. Elsevier. (n.d.). Scopus author search and author identification. Scopus Support Center.
    https://www.scopus.com/pages/authors/6602073871
  2. International Material Scientist Awards. (n.d.).
    https://materialscientists.com
  3. Aristidou, A. A. (2000). Metabolic engineering applications to renewable resource utilization. Current Opinion in Biotechnology, 11(2), 187–198.
    https://doi.org/10.1016/S0958-1669(00)00085-9
  4. Aristidou, A. A. (n.d.). Aristos Aristidou. Texas A&M University, Department of Chemical Engineering.
    https://orcid.org/0000-0002-4873-3639

Dr Feryal Akay | Biomaterials | Best Researcher Award

Dr Feryal Akay | Biomaterials | Best Researcher Award

Dr. Feryal Akay is a PhD graduate in Chemistry from Dicle University (2023), specializing in human immunoglobulin G glycation and the effects of Morus nigra leaf extract on DNA glycation. She has participated in key national projects and has contributed to high-impact publications in journals like Archives of Biochemistry and Biophysics (2025) and Indian Journal of Biochemistry and Biophysics (2024). With experience as an Ar-Ge specialist at Labixir, Dr. Akay is deeply committed to advancing glycation research and is a strong candidate for the Best Researcher Award. 📚🧬🌿

Dr Feryal Akay, University of Dicle, Turkey

Profile

ORCID

SCOPUS

Education🎓

Dr. Feryal Akay completed her PhD in Chemistry at Dicle University in 2023, with a thesis on the glycation of human immunoglobulin G and its impact on antigen binding, supervised by Prof. Dr. Göksel Kızıl and Prof. Dr. Beran Yokuş. She also earned her Master’s in Chemistry from the same university in 2018, focusing on the effects of Morus nigra leaf ethanol extract on DNA glycation. Dr. Akay completed her Bachelor’s degree in Chemistry in 2015 at Dicle University’s Faculty of Science. 🎓🧪📜

Experience🩺

Dr. Feryal Akay worked as an Ar-Ge (Research and Development) Specialist at Labixir, a pharmaceutical analysis laboratory, from November 2021 to August 2022. In this role, she contributed to various research and development projects, specializing in pharmaceutical analysis and innovative techniques in the field. Her work involved analyzing and improving the efficacy of pharmaceutical products, contributing to the advancement of the pharmaceutical industry. Dr. Akay’s experience in this commercial sector allowed her to apply her academic expertise in a practical, real-world environment, further enhancing her skill set in both research and pharmaceutical development. 💊🔬🧪

Certificate 🏅

Dr. Feryal Akay has earned several prestigious certificates for her participation in international conferences. She attended the 1st International Multidisciplinary Cancer Research Congress held at Dicle University in Diyarbakır from 18-22 September 2019. She also participated in the INESEC 2018, The International Engineering Natural Science Conference, from 14-17 November 2018. Additionally, Dr. Akay presented a Oral Presentation at the 6th International Congress on Pharmaceutical Chemistry in Antalya/Belek, held by Atatürk University and the Chemists Association, from 22-25 March 2018. 🏅🎓🌍📚

Research Focus 🔬

Dr. Feryal Akay’s research primarily focuses on glycation and its impact on immune function. Her studies explore how fructose-derived glycation affects antigen binding in human IgG and lymphocytes, aiming to better understand the role of glycation in immune responses (Archives of Biochemistry and Biophysics, 2025). Additionally, Dr. Akay has investigated the inhibitory effects of Morus nigra leaf extract on DNA glycation and its potential in preventing advanced glycation end products (Indian Journal of Biochemistry and Biophysics, 2024). Her work also includes the antiglycative effects of Capsicum annuum (chili) and pyridoxamine in experimental diabetes models (Revista Brasileira de Farmacognosia, 2023). 🌱🧬🔬

Publications📚

Fructose-derived glycation and immune function: Effects on antigen binding in human IgG and lymphocytes 🧬

  • Authors: Feryal Akay, Nesrin İnceören, Cemal Nas, Beran Yokuş, Göksel Kızıl, Murat Kızıl
  • Journal: Archives of Biochemistry and Biophysics

Evaluation of ethanol extract of Morus nigra L. as an inhibitory agent for DNA-Advanced glycation end product (DNA-AGEs) 🍃

  • Authors: Feryal Akay
  • Journal: Indian Journal of Biochemistry and Biophysics

Antiglycative Effect of Combination of Extracts of Capsicum annuum (chilli) and Pyridoxamine Against Glycation in Streptozotocin-induced Experimental Diabetes in Rats 🌶️

  • Authors: Nesrin İnceören, Feryal Akay, Cemal Nas, Engin Deveci, Göksel Kızıl, Murat Kızıl
  • Journal: Revista Brasileira de Farmacognosia

Determination Of Antioxidant Activity of Dietary Selenium, Oleuropein, Glutathione Mixture 🥗

  • Authors: Feryal Akay, Göksel Kızıl
  • Journal: European Journal of Technic